AR SB341

Requires physicians or qualified persons to provide written notice to patients after dispensing the first dose of mifepristone (RU-486/Mifeprex) informing them that reversal may be possible if the second pill has not been taken.

Notice must inform patients they can search "abortion pill reversal" on the internet to locate immediate help if they wish to continue their pregnancy.

Amends the Woman's Right-to-Know Act to require inclusion of information about the potential ability to reverse effects of abortion-inducing drugs in published materials.

Requires department materials to include directions to access the department website and other appropriate telephone and internet resources for assistance in locating healthcare professionals who can aid in drug reversal.

Bill was approved on March 20, 2019, and includes a severability clause protecting the act if any provision is found invalid.